HighTower Advisors
BLFS icon

HighTower Advisors’s BioLife Solutions BLFS Stock Holding History

HighTower Advisors’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-12,717
Closed -$268K – 3760
2024
Q2 		$268K Buy
+12,717
New +$247K ﹤0.01% 2807
2023
Q4 		– Sell
-17,637
Closed -$246K – 3649
2023
Q3 		$246K Buy
+17,637
New +$278K ﹤0.01% 2747
2023
Q1 		– Sell
-25,334
Closed -$460K – 3424
2022
Q4 		$460K Buy
+25,334
New +$523K ﹤0.01% 2180
2022
Q3 		– Sell
-93,767
Closed -$1.29M – 3173
2022
Q2 		$1.29M Buy
93,767
+80,454
+604% +$1.18M ﹤0.01% 1492
2022
Q1 		$302K Buy
13,313
+7,856
+144% +$207K ﹤0.01% 2521
2021
Q4 		$204K Sell
5,457
-19
-0.3% -$815 ﹤0.01% 2763
2021
Q3 		$231K Buy
5,476
+183
+3% +$8.81K ﹤0.01% 2603
2021
Q2 		$235K Buy
+5,293
New +$186K ﹤0.01% 2551
2021
Q1 		– Sell
-5,013
Closed -$200K – 3062
2020
Q4 		$200K Buy
+5,013
New +$171K ﹤0.01% 2202

Other funds holding BLFS

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
CRM
Cramer Rosenthal McGlynn Stamford, Connecticut $1.36B AUM 31.72% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return

HighTower Advisors's BLFS Position: Q3 2024 in Review

HighTower Advisors sold out of BioLife Solutions (BLFS) in Q3 2024, closing a stake of 12,717 shares — an estimated $268K sold.

HighTower Advisors first reported a position in BLFS in Q4 2020 and held it in 9 quarters. The position peaked at $1.29M in Q2 2022. 195 funds tracked by Wall St. Rank hold BLFS as of Q3 2024.

  • HighTower Advisors reported no remaining BioLife Solutions position as of Q3 2024 after selling out during the quarter.
  • HighTower Advisors sold 12,717 BioLife Solutions shares in Q3 2024, an estimated $268K.
  • HighTower Advisors first reported a position in BioLife Solutions in Q4 2020 and held it in 9 quarters.
  • HighTower Advisors's BioLife Solutions position peaked at $1.29M in Q2 2022.
  • 195 funds tracked by Wall St. Rank held BioLife Solutions as of Q3 2024.

Based on HighTower Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.